Skip to main content
. 2021 Mar 9;27:e928478-1–e928478-12. doi: 10.12659/MSM.928478

Figure 2.

Figure 2

Weight loss and clinical activity score (CAS) of mice in the treated and pretreated groups. (A) No significant difference in weight loss was observed between the treated SL and treated BB groups. (B) Significantly less weight loss was observed in the pretreated BB group from days 31 to 34. (C) CASs of the treated BB group were remarkably reduced compared with those of the treated TL group (P=0.001). (D) CASs of the pretreated BB group were significantly decreased compared with those of the pretreated TL group (P=0.000). * P<0.05.